Cadrenal Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Cadrenal Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($2.69M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($3.67M) | Aug 11, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($3.85M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($2.41M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($2.39M) | Aug 11, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($1.66M) | May 8, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.04M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.00M) | Aug 7, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($5.17M) | May 9, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($1.03M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($502.1K) | Aug 10, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($176.6K) | May 10, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($2.73M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($3.73M) | Aug 11, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($3.93M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($2.46M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($2.47M) | Aug 11, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($1.76M) | May 8, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.14M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.03M) | Aug 7, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($4.20M) | May 9, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($972.8K) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($482.3K) | Aug 10, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($170.5K) | May 10, 2023 |